Need help with Investor Relations? Read our latest eBook. Download Now

Westicke Partners IPO Advisory
Strategic Investor Relations
Independent Capital Markets Advice

Mobile Navigation

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of investor relations and the capital markets, with a specific focus on the healthcare industry.

Why Private Companies Need to Meet with Sell-Side Analysts

Posted on April 10th, 2014. Posted by

Private companies often tell us about the considerable time and effort they spend meeting with investment bankers and sharing insights on their business, out of hope that these bankers will take an interest in underwriting their IPO. Yet when we ask which sell-side research analysts they’ve met, we are typically met with a blank stare.

Many executives don’t understand the importance and value of meeting with sell-side analysts while still a private company. In fact, most management teams don’t realize that research analysts actually want to meet management teams of private companies. For sell-side analysts, meeting with private companies enables them to build an early relationship with promising companies and gain valuable insights on the industry and products.

Continue Reading

Make Your Non-Deal Road Shows More Efficient and Effective

Posted on March 5th, 2014. Posted by

This time of year, Wall Street is abuzz with opportunities to meet, greet, and hear firsthand from you and your management team about what’s happening with your company. There are requests to “go on the road” with virtually every sell-side firm, whether an analyst from the firm covers your company or not. There are also countless investor conferences, bus trips, and industry events — all of which you will be asked to participate in.

The buy side values access to the C-suite probably more than anything else. In fact, many of the major investment firms base the commission they pay brokers on how many management teams they provide access to each quarter. A great deal of money is tied up in these events, so they are important.

Continue Reading

Top 10 Benefits of Non-Deal Road Shows

Posted on February 19th, 2014. Posted by

Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS). It’s critical, however, to pinpoint the right city and sponsoring analyst to make the most of the trip.

Non-deal road shows involve planning and work but can deliver meaningful results. Below are what we consider the top 10 benefits.

Continue Reading

How to Create a Solid Investor Relations Plan in 2014

Posted on January 15th, 2014. Posted by

How can you align your investor relations (IR) efforts with your overall corporate strategy and messaging? How do you balance IR activities with other demands on your time as a management team? Here are several tips from the Westwicke team to help ensure that the strategic investor relations plan you create at the beginning of the year delivers the desired results.

Continue Reading

Plan Now for the J.P. Morgan Healthcare Conference

Posted on November 20th, 2013. Posted by

For 31 years running, the mosh-pit that is J.P. Morgan’s Healthcare Conference kicks off the new year. In addition to the more than 400 companies that officially present, the conference attracts countless other healthcare companies looking to meet with the investment community. It is also the only event that attracts sell-side analysts and investment bankers from all corners of Wall Street.

Continue Reading

Top 10 Credibility Busters

Posted on October 16th, 2013. Posted by

Over time, all management teams want to build relationships, or at least a healthy rapport, with shareholders. Consistent execution of your business plan and proper communication with current and potential shareholders can help you build credibility, which in turn can bolster your company’s valuation and even allow your management team to earn “the benefit of the doubt” when things are not easy.

Last month, we looked at the top 10 ways companies can build credibility with shareholders. This month, we consider the opposite, and explore common ways companies get into hot water. Here are the top 10 credibility busters you want to work hard to avoid.

Continue Reading

The Sell-Side Perspective — Wall Street Revealed Webinar Highlights

Posted on September 27th, 2013. Posted by

Sell-side analysts hold big sway with the investment community, and can help your company’s potential to attract investors. To work in your favor, analysts must know the ins and outs of why your company or product represents the next best thing in the marketplace. They also need confidence in your company’s potential to make it to the next level.

While the reputation of sell-side analysts came under fire with conflict of interest stories this past decade, and new regulations helped level the playing field, analysts continue to play powerful roles in the marketplace, and companies are wise to nurture strong relationships. What’s it like in today’s market from the sell-side point of view? And how can you better your chances of making it on analysts’ coverage lists and receiving a coveted “Buy” rating? Continue Reading

Three Tips for Working With Your Analysts

Posted on August 21st, 2013. Posted by

Three Tips for Working With Your Analysts

Over the last decade, various regulatory adjustments have dramatically changed the buy-side/sell-side scenario and how companies interact with both sides of The Street. In 2000, the SEC adopted Regulation FD, which aims to promote the full and fair disclosure of information by publicly traded companies. Two years later, Sarbanes-Oxley mandated reforms to enhance corporate transparency and reduce conflicts of interest among securities analysts. Crucially, today, management teams need to provide the same information to both sell- and buy-side analysts.

The following are a few tips to help you better manage your analyst relationships:

  1. Keep the talking points consistent between the sell-side and buy-side analysts. Regulation FD mandates that you treat both sides equally. Be straightforward, transparent and candid with both. Shareholders that receive different information from the analysts will take this as a red flag.
  1. Appreciate the nuances between buy- and sell-side analysts. It’s important to understand that buy- and sell-side analysts have different jobs and play different roles.  For instance, the sell-side analyst needs to have a price target over the next year.  The buy-side analyst may create a target price over the next three years.  As a result, each may interpret the exact same information differently. Continue Reading

Top 10 Reasons Analyst Ratings Don’t Matter

Posted on May 15th, 2013. Posted by

Top 10 Reasons Analyst Ratings Don’t Matter

Management teams and IR professionals tend to take stock rating downgrades personally.  While a downgrade may sting on the day of, in the long run all stocks’ ratings are subject to fluctuations – both up and down.  To get a better feel for how the buy-side reacts to ratings downgrades, we reached out to both buy-side analysts and portfolio managers to get some real-time feedback.  The conclusion? In general, the buy-side really doesn’t care about the rating on a particular stock.  The representatives we spoke to clearly are more interested in learning as much as possible about a company and are less interested in a stock’s label.

Following are ten direct quotes about this topic that speak to why analyst ratings really don’t matter:

  1. “I don’t care about analyst ratings. I do my own research and try not to let the sell-side influence me.”
  2. “I love analyst downgrades because it gives me an opportunity to buy the stock.”
  3. “Most of the time I don’t even know what their ratings are, I just talk to the analysts that know the company the best.”
  4.  “I’ve done this for long enough to know that more than half of them are wrong on their ratings.”
  5. “Sometimes ratings are based on momentum and not fundamentals.  I invest in fundamentals.” Continue Reading

Negative Analysts: 3 Strategic Steps For Managing Them

Posted on April 3rd, 2013. Posted by

Negative Analysts: 3 Strategic Steps For Managing Them

Sell ratings got you bothered? Can’t shake the feeling that an analyst is holding a grudge? Wish you could just make them go away?

Let’s discuss your negative analyst strategy in 3 steps:

 

  1. Remember the big picture
  2. Avoid the pitfalls
  3. Engage and execute

1. Remember the big picture.

There will always be analysts who are negative on your company. They won’t go away. Why?

Continue Reading

READ OUR INSIDER’S GUIDE TO INVESTOR RELATIONS

Click here to download our latest eBook, Westwicke Partners Insider’s Guide to Investor Relations, for our team’s insights on all things IR-related.

LEARN MORE

Our Locations